<i>In silico</i>optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a ‘parallel progression approach to drug design’ applied to β-blockers
Poonam Advani(Shreemati Nathibai Damodar Thackersey Women's University), Evans C. Coutinho(Bombay College of Pharmacy), K. R. Krishna Iyer(University of Michigan), Vijay M. Khedkar(National Chemical Laboratory), Blessy Joseph(Bombay College of Pharmacy), Raghuvir R. S. Pissurlenkar(Bombay College of Pharmacy), Radhakrishnan P. Iyer, Satish Y. Gabhe(Bharati Vidyapeeth Deemed University), Premlata Ambre(Bombay College of Pharmacy)
Cited by 1
Related Papers
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Advanced Dressings for Chronic Wound Management
|ACS Applied Bio Materials|2024|87
Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations
|Chemico-Biological Interactions|1999|66
Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study
|Colloids and Surfaces B Biointerfaces|2016|61
5,6-Dihydropyran-2-ones Possessing Various Sulfonyl Functionalities: Potent Nonpeptidic Inhibitors of HIV Protease
|Journal of Medicinal Chemistry|2000|51